Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05971342
Other study ID # Mao Xue Li
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date August 20, 2023
Est. completion date December 30, 2024

Study information

Verified date July 2023
Source Fifth Affiliated Hospital of Guangzhou Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Distal bone loss of the second molar due to extraction of the third molar is one of the most common pathological conditions that results in tooth loss of second molar. However, regeneration of functional alveolar bone has proved difficult. Therefore, the investigators conduct a two-arm study to evaluate the efficacy and safety of alveolar bone regeneration induced by gelatin sponge-loaded apoptotic vesicle complex in patients with mandibular third molar extraction.


Description:

This study is a single-center, prospective, two-arm study to evaluate the efficacy and safety of alveolar bone regeneration induced by gelatin sponge-loaded apoptotic vesicle complex in patients with mandibular third molar extraction. This study plans to include 30 subjects from the Department of Stomatology of the Fifth Affiliated Hospital of Guangzhou Medical University. One socket for each participant in this study will receive gelatin sponge-loaded apoptotic vesicle complex after third molar extraction and socket debridement. The other side of socket for each participant in this study will receive commercial gelatin sponge after the same surgery. All participants will undergo screening and baseline visits. After surgery, the participants will be followed up for 1 year.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date December 30, 2024
Est. primary completion date October 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: 1. Patients aged 18-45 (including the boundary value) 2. Patients who need to extract the bilateral mandible third molars 3. Patients who voluntarily sign the informed consent form Exclusion Criteria: 1. The adjacent second molars in the patient's oral cavity are affected by pulp injury or insufficient endodontic treatment, or show tooth fracture, or have a degree of motion of 3 degrees 2. The adjacent second molars have metal crowns or large amalgam restorations 3. There is an uncontrollable pathological process in the patient's oral cavity 4. Malnutrition (serum albumin concentration <2 g/dl) 5. Other systemic, infectious diseases and hereditary diseases, or patients in the acute inflammatory phase and acute exacerbation phase of chronic diseases 6. Patients who are pregnant, lactating, or planning to become pregnant

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Gelatin sponge-loaded apoptotic vesicle complex(Kuaikang®)
The experimental group
Gelatin sponge only (Kuaikang®)
The positive control group

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Fifth Affiliated Hospital of Guangzhou Medical University

Outcome

Type Measure Description Time frame Safety issue
Primary Bone volume fraction of regenerated bone tissue in the extraction area at 3 months after operation CBCT is a cone-beam projection computerized reconstruction tomography device. Its principle is that the X-ray generator uses a low radiation dose to make a circular DR (digital projection) around the projection body. Then the data obtained in the "intersection" after digital projection around the projection body multiple times is "reconstructed" in the computer to obtain a three-dimensional image. CBCT can observe the three-dimensional level of bone regeneration, so as to calculate the bone volume fraction of the regenerated bone tissue. 3 months
Secondary Hemostatic time after third molar extraction After the third molar was completely extracted, commercial gelatin sponge or gelatin sponge loaded with apoptotic vesicle complex were placed in the socket. The time to hemostasis in the extraction socket was observed and recorded at the same time. 0 day
See also
  Status Clinical Trial Phase
Completed NCT02273999 - Pulsed Electromagnetic Fields for Postoperative Pain: a Linical Trial in Humans N/A
Completed NCT00390312 - Efficacy and Safety of Intranasal Morphine for Pain After Third Molar Extraction Phase 2
Completed NCT03428698 - Hyaluronic Acid and Amino Acid Gel Applied to the Alveolar Socket After Mandibular Third Molar Extraction N/A
Withdrawn NCT05683574 - Fixed-dose Combination of Etoricoxib + Cyclobenzaprine for Pain Relief After Third Molar Extraction in Brazil Phase 3
Recruiting NCT04647435 - Efficacy and Safety of APSCTC for the Treatment of Postsurgical Pain Due to Third Molar Extraction Phase 3
Completed NCT01541059 - Postoperative Analgesia Following Wisdom Teeth Removal: Ropivacaine Versus Placebo Phase 4
Completed NCT00707057 - Ibuprofen Extended-Release Dental Pain Study Phase 3
Completed NCT00971178 - Analgesic Effect of Peripheral Dexmedetomidine Phase 3
Completed NCT05255731 - Effect of Low Power Laser in the Pain After Lower Tooth Extraction N/A
Not yet recruiting NCT05540015 - Use of Erbium Laser for Extraction of the Third Molars N/A